NEWS

Sensome announces initiation of clinical trial assessing its tissue micr...

PARIS, FRANCE - FEBRUARY 12TH, 2024 – Sensome, the company pioneering the connected medical device revolution with the world’s smallest biological tissue sensor, announced today enrollment of the first patients into a feasibility clinical study using the Clotild® Smart Guidewire in peripheral artery disease (PAD). Clotild® was designated a breakthrough medical device for use in brain arteries by the FDA in 2021.

Case of giant aneurysm using Flow Diverter

'INR Stories: The Uncensored Interview'. Podcast episode 3!

Treating large vessel occlusion acute ischemic stroke

Our esteemed faculty has a message for you!

Pediatric ICA aneurysm: treatment unveiled!

'INR Stories: The Uncensored Interview'. Podcast episode 2!

Relive the thrills of LINNC ASIA 2023 in Seoul!

Interested in Stroke and Aneurysm management?

Interested in Stroke and Aneurysm management? Join us for the Second Day!